Resveratrol Nanoparticle Encapsulation for Bioavailability and Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing formulations of resveratrol (RSV) face challenges in enhancing bioavailability and targeted delivery to specific sites within the body, leading to inefficiencies in treating diseases such as Alzheimer's disease, atherosclerosis, cancer, chronic liver disease, Type 2 diabetes, heart disease, hypertension, and stroke.
Innovation Solution
Encapsulating RSV with a gum arabic shell and a polyvinyl alcohol coating to form nanoparticles with a size range of 195-210 nm and a PDI of 0.195-0.225, enhancing targeted delivery and bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If resveratrol is used in conventional formulations, then it can provide curative properties for various diseases, but its bioavailability is insufficient and targeted delivery is limited
Solution Approach 1:
The patent segments resveratrol into nanoparticle form, dividing the bulk substance into discrete nanoscale units (195-210 nm) that can be selectively delivered to target sites. This segmentation enables improved bioavailability while maintaining the curative properties of resveratrol for treating diseases such as Alzheimer's, cancer, and cardiovascular conditions.
Solution Approach 2:
The patent employs a nested structure where resveratrol is encapsulated within a gum arabic shell, which is further coated with polyvinyl alcohol. This multi-layer nesting protects the resveratrol core while enabling controlled release and targeted delivery to specific tissues, thereby resolving the contradiction between bioavailability and targeted delivery efficiency.
2Manufacturing precision
If resveratrol nanoparticles are formulated with gum arabic and polyvinyl alcohol coating, then targeted delivery is enhanced, but the manufacturing process becomes more complex
Solution Approach 1:
The patent uses composite materials by combining resveratrol with gum arabic and polyvinyl alcohol in a specific ratio (1:5:5 w/w/w). This composite formulation enables precise control over nanoparticle size (195-210 nm) and properties while maintaining a manageable manufacturing process through standardized mixing and homogenization steps.
3Ease of operation
If conventional resveratrol formulations are used, then they can be administered orally, but they fail to achieve sufficient concentration at target sites
Solution Approach 1:
The patent transitions from bulk resveratrol administration to nanoscale delivery, operating at a different scale (nanometer dimension). This dimensional change enables the resveratrol to penetrate biological barriers more effectively and accumulate at target sites at sufficient concentrations while maintaining ease of oral administration through the nanoparticle formulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The encapsulated RSV nanoparticles effectively increase Bcl-2 immunoreactivity, reduce apoptosis, and enhance CAR gene expression, providing therapeutic benefits for diseases of civilization, including Alzheimer's disease, cancer, chronic liver disease, Type 2 diabetes, heart disease, hypertension, and stroke.
Implementation Method 1
encapsulating RSV with a gum arabic shell and a polyvinyl alcohol coating to form nanoparticles
Implementation Method 2
The encapsulated RSV nanoparticles effectively increase Bcl-2 immunoreactivity, reduce apoptosis
Implementation Method 3
enhance CAR gene expression, providing therapeutic benefits for diseases of civilization
Data Source
AI summary
Encapsulated resveratrol (RSV) nanoparticles having a resveratrol core, a gum arabic shell, and a polyvinyl alcohol coating over the gum arabic shell. In an embodiment, an RSV:gum arabic:polyvinyl alcohol (PVA) ratio in the encapsulated nanoparticles is about 1:5:5 (w/w/w). The encapsulated RSV nanoparticles can have an average size ranging from about 195 nm to about 210 nm.